Louis Staudt
路易斯·斯托特
MD, PhD
Director, Center for Cancer Genomics; Senior Investigator癌症基因组学中心主任兼高级研究员
👥Biography 个人简介
Louis Staudt is a pioneering molecular oncologist who defined the ABC and GCB subtypes of DLBCL through gene expression profiling. His laboratory elucidated the role of chronic active BCR signaling and NF-kB activation in ABC-DLBCL, providing the biological rationale for BTK inhibitor therapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
ABC/GCB DLBCL Classification
Discovered the two major molecular subtypes of DLBCL (ABC and GCB) with distinct cells of origin, signaling pathways, and clinical outcomes.
BTK Inhibitor Rationale
Demonstrated that ABC-DLBCL depends on chronic active BCR-NF-kB signaling, establishing the biological basis for ibrutinib and other BTK inhibitor trials.
Cancer Genomics Leadership
Leads NCI's Center for Cancer Genomics, advancing genomic classification and precision oncology across multiple lymphoma and leukemia subtypes.
Representative Works 代表性著作
Distinct Types of Diffuse Large B-Cell Lymphoma Identified by Gene Expression Profiling
Nature (2000)
Foundational study establishing ABC and GCB DLBCL as biologically distinct diseases with different prognoses.
Oncogenic Activation of NF-κB by Chronic Active B-Cell Receptor Signaling
Nature (2010)
Revealed mechanism driving ABC-DLBCL survival, directly motivating clinical trials of BTK inhibitors in this subtype.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Elaine Jaffe
National Cancer Institute, NIH
Nancy Lee Harris
Massachusetts General Hospital, Harvard Medical School
Philippe Gaulard
Henri Mondor Hospital, Paris Est University
Andreas Rosenwald
University of Würzburg
关注 路易斯·斯托特 的研究动态
Follow Louis Staudt's research updates
留下邮箱，当我们发布与 Louis Staudt（National Cancer Institute, NIH）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment